Initial clinical experience with fazadinium bromide during anaesthesia in Nigerians
- PMID: 6136134
Initial clinical experience with fazadinium bromide during anaesthesia in Nigerians
Abstract
Fazadinium Bromide (Fazadon, AH 8165), a non depolarising muscle relaxant, was injected into one hundred unpremedicated Nigerian patients requiring endotracheal intubation and prolonged skeletal muscle relaxation. The dose of Fazadon used was 1.5 mg per kg. body weight. Endotracheal intubation was possible in all the patients within thirty seconds of the intravenous injection of Fazadon. The initial single dose of the drug provided muscle relaxation for an average of forty minutes without the addition of any volatile anaesthetic agent. Arterial blood pressure was well maintained, but there was a mean increase in pulse rate of 20 beats per minute. Return of skeletal muscle activity was observed within one minute of the injection of neostigmine, in all but one patient.
Similar articles
-
Clinical trial of fazadinium bromide (fazadon).Can Anaesth Soc J. 1981 Mar;28(2):149-52. doi: 10.1007/BF03007259. Can Anaesth Soc J. 1981. PMID: 6113885 Clinical Trial.
-
Comparative evaluation of neuromuscular blockade and reversibility of AH 8165 and pancuronium bromide in man.Acta Anaesthesiol Belg. 1976;27 suppl:80-5. Acta Anaesthesiol Belg. 1976. PMID: 13601
-
Clinical evaluation of a new non-depolarising muscle relaxant.S Afr Med J. 1974 Dec 14;48(61):2561-4. S Afr Med J. 1974. PMID: 4281529 No abstract available.
-
[Clinical administration of muscle relaxants for intubation].Anaesthesiol Reanim. 2001;26(5):116-22. Anaesthesiol Reanim. 2001. PMID: 11712228 Review. German.
-
[Pharmacology of fazadinium (AH 8165)].Ann Anesthesiol Fr. 1981;22(6):631-9. Ann Anesthesiol Fr. 1981. PMID: 6124193 Review. French. No abstract available.